Charles L. Litterst
- Oncology top 5%
- Molecular Biology top 10%
- Pathology and Forensic Medicine top 2%
- Pharmacology top 0.5%
- Cancer Research top 10%
- Co-authors
- Theodore E. GramEdward G. MimnaughAnthony M. GuarinoEdward J. Van LoonReginald L. ReaganRobert L. DedrickA LeroyBranimir I. Šikić
- Topics
- Pharmacogenetics and Drug Metabolism (23 papers)Drug Transport and Resistance Mechanisms (23 papers)Chemotherapy-induced organ toxicity mitigation (14 papers)
- Journals
- JNCI Journal of the National Cancer InstituteJournal of Agricultural and Food ChemistryEnvironmental Health Perspectives
- Partner nations
- United StatesMalaysiaUkraine
In The Last Decade
Charles L. Litterst
69 papers receiving 2.5k citations
Peers
Comparison fields: 5 of 123
- Oncology 908
- Molecular Biology 731
- Pathology and Forensic Medicine 603
- Pharmacology 508
- Cancer Research 296
Countries citing papers authored by Charles L. Litterst
This map shows the geographic impact of Charles L. Litterst's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Charles L. Litterst with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Charles L. Litterst more than expected).
Fields of papers citing papers by Charles L. Litterst
This network shows the impact of papers produced by Charles L. Litterst. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Charles L. Litterst. The network helps show where Charles L. Litterst may publish in the future.
Co-authorship network of co-authors of Charles L. Litterst
This figure shows the co-authorship network connecting the top 25 collaborators of Charles L. Litterst. A scholar is included among the top collaborators of Charles L. Litterst based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Charles L. Litterst. Charles L. Litterst is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 23 | |
| 2 | 22 | |
| 3 | 83 | |
| 4 | 2 | |
| 5 | 3 | |
| 6 | 4 | |
| 7 | 8 | |
| 8 | 71 | |
| 9 | 38 | |
| 10 | 47 | |
| 11 | 20 | |
| 12 | 10 | |
| 13 | 3 | |
| 14 | 41 | |
| 15 | 4 | |
| 16 | 38 | |
| 17 | 11 | |
| 18 | 4 | |
| 19 | 4 | |
| 20 | 151 |
About Charles L. Litterst
Charles L. Litterst is a scholar working on Pharmacology, Oncology and Pathology and Forensic Medicine, having authored 71 papers that have together received 2.6k indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (23 papers), Drug Transport and Resistance Mechanisms (23 papers) and Chemotherapy-induced organ toxicity mitigation (14 papers). The work is most often cited by research in Pharmacology (508 citations), Pathology and Forensic Medicine (603 citations) and Oncology (908 citations). Charles L. Litterst has collaborated with scholars based in United States, Malaysia and Ukraine. Frequent co-authors include Theodore E. Gram, Edward G. Mimnaugh, Anthony M. Guarino, Edward J. Van Loon, Reginald L. Reagan, Robert L. Dedrick, A Leroy, Branimir I. Šikić, Theodore M. Färber and Amy Baker. Their work appears in journals such as JNCI Journal of the National Cancer Institute, Journal of Agricultural and Food Chemistry and Environmental Health Perspectives.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.